Open AccessGlycated albumin as a biomarker for diagnosis of diabetes mellitus: A systematic review and meta-analysis
Author(s) -
Jiayao Xiong,
Junmei Wang,
Xiaolan Zhao,
Chao Yang,
Xianshu Jiang,
Yanmei Chen,
Chang-Qin Chen,
Zhiyong Li
Publication year - 2021
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v9.i31.9520
Subject(s) - medicine , receiver operating characteristic , diabetes mellitus , glycemic , meta analysis , glycated hemoglobin , gestational diabetes , area under the curve , glycemic index , biomarker , endocrinology , type 2 diabetes , pregnancy , gestation , biochemistry , chemistry , biology , genetics
Glycated albumin (GA), the non-enzymatic glycation product of albumin in plasma, became a glycemic marker in the beginning of the 21st century. The assay is not affected by hemoglobin levels and reflects the glycemic status over a shorter period as compared to HbA1c measurements. Thus, GA may contributes as an intermediate glucose index in the current diabetes mellitus (DM) diagnostic system.